Found 16 matching trials
A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors PHASE1 This study was designed to evaluate the efficacy and safety of 7MW3711 in c...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors PHASE1 This study is an open-label, dose-escalation and expansion, Phase I clinica...
Show More Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
Learn More & Join Trial
JS212 Combination Therapies in Metastatic Colorectal Cancer PHASE2 This is an open-label, multicenter Phase 2 clinical study designed to evalu...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma PHASE2 This open-label, multicenter phase II study was designed to evaluate the sa...
Show More Location
The First Affiliated Hospital of USTC
Learn More & Join Trial
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors PHASE1 This is a phase I/II study to preliminarily explore of the safety, tolerabi...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer PHASE2 This is a multicenter, open-label Phase II clinical study, with the main ob...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer PHASE2 This study is an open label, multicenter Phase II clinical trial aimed at e...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy PHASE2 This study targets patients with advanced NSCLC driven with positive driver...
Show More Location
Guangdong Provicial People's Hospital
Learn More & Join Trial
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors PHASE2 This is a multicenter, open-label Phase II clinical study. The primary obje...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial